Trial Profile
Effects of simvastatin and ezetimibe on PCSK9 levels in healthy men
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jul 2013
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Simvastatin (Primary)
- Indications Dyslipidaemias
- Focus Pharmacodynamics
- 10 Jul 2013 New trial record
- 18 Jun 2013 Results presented at the 95th Annual Meeting of the Endocrine Society.